Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

<p>Abstract</p> <p>Background</p> <p>Antiangiogenesis is a promising therapy for advanced hepatocellular carcinoma (HCC), but the effects are difficult to be evaluated. Pazopanib (GW786034B) is a pan-vascular endothelial growth factor receptor inhibitor, the antitumor e...

Full description

Bibliographic Details
Main Authors: Wu Wei-Zhong, Wang Lu, Kong Ling-Qun, Gao Dong-Mei, Xu Hua-Xiang, Zhang Wei, Zhuang Peng-Yuan, Xiong Yu-Quan, Fan Pei-Li, Zhang Ju-Bo, Zhu Xiao-Dong, Tang Zhao-You, Ding Hong, Sun Hui-Chuan
Format: Article
Language:English
Published: BMC 2011-01-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/28

Internet

http://www.biomedcentral.com/1471-2407/11/28

Similar Items